CPHI China Pharma
- 0.2259
- -0.0001-0.04%
- 0.2198
- -0.0061-2.70%
China Pharma News
China Pharma | 3: Initial statement of beneficial ownership of securities-10% Owner Liu Tao (Chengdu)
China Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Tao Liu(27.3%)
China Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
China Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Li Zhilin
China Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ke Deng(19.4%)
China Pharma | 3: Initial statement of beneficial ownership of securities-10% Owner Deng Ke
China Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
China Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
China Pharma | D: Filing D
China Pharma | 4: Statement of changes in beneficial ownership of securities
China Pharma | 4: Statement of changes in beneficial ownership of securities
China Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
China Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China Pharma | 4: Statement of changes in beneficial ownership of securities
China Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
China Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Analysis
Price Target
No Data
No Data
